Kane Biotech Inc KNBIF

Primary Symbol: V.KNE

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc > New Press Release - Kane Biotech Announces Special Meeting of Shareholders

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jan 18, 2024 10:14pm

95 Views

Post# 35835189

RE:New Press Release - Kane Biotech Announces Special Meeting of Shareholders

Waste of money.....

Date: January 18, 2024 at 8:12:44PM MST
To: rdupuis@kanebiotech.com
Subject: Shareholder Comment

Hello,
I don’t understand the need to hold a special meeting just to elect a director. Every other co. just waits until the annual general meeting. Seems like an unnecessary expense.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"